Regeneron Pharmaceuticals
$89.89 B
Share price
Change (1 day)
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2023$72.96 M-42.33%
2022$0.12 B-53.05%
2021$0.26 B5.23%
2020$0.25 B414.86%
2019$49.73 M-31.98%
2018$73.11 M69.52%
2017$43.12 M-78.72%
2016$0.20 B3.03%
2015$0.19 B-15.29%
2014$0.23 B419.89%
2013$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.30 B$0.50 B๐Ÿ‡บ๐Ÿ‡ธ USA
$10.06 M$52.33 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$22.23 M$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
$8.99 M$87.65 M๐Ÿ‡ซ๐Ÿ‡ท France
$29.51 M$74.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.62 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA